Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2013-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla
NCT02986594
Study on Antithrombotic Prevention in Thrombophilia and Pregnancy Loss
NCT02385461
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
NCT01068795
Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients
NCT01744431
Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
NCT00149357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnant womens
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed inform consent
* first trimester
* two early miscarriages(before week 10) or one later abortions (after week 10)
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elias mazen
Director of Internal medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mazen elias, prof
Role: PRINCIPAL_INVESTIGATOR
HaEmek Medical Center, Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haemek medical center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
thrombin generation- pregnancy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.